175 related articles for article (PubMed ID: 30227240)
21. Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis.
Togami K; Kanehira Y; Tada H
Biol Pharm Bull; 2013; 36(10):1525-7. PubMed ID: 24088250
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats.
Punithavathi D; Venkatesan N; Babu M
Br J Pharmacol; 2003 Aug; 139(7):1342-50. PubMed ID: 12890714
[TBL] [Abstract][Full Text] [Related]
23. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
[TBL] [Abstract][Full Text] [Related]
24. Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer.
Grill AE; Shahani K; Koniar B; Panyam J
Drug Deliv Transl Res; 2018 Apr; 8(2):329-341. PubMed ID: 28417445
[TBL] [Abstract][Full Text] [Related]
25. Relaxin-Loaded Inhaled Porous Microspheres Inhibit Idiopathic Pulmonary Fibrosis and Improve Pulmonary Function Post-Bleomycin Challenges.
Qiu S; Fu X; Shi Y; Zang H; Zhao Y; Qin Z; Lin G; Zhao X
Mol Pharm; 2023 Aug; 20(8):3947-3959. PubMed ID: 37358639
[TBL] [Abstract][Full Text] [Related]
26. Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs.
Patel B; Rashid J; Ahsan F
Eur J Pharm Sci; 2017 Jan; 96():560-570. PubMed ID: 27989858
[TBL] [Abstract][Full Text] [Related]
27. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
28. N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro.
Cu A; Ye Q; Sarria R; Nakamura S; Guzman J; Costabel U
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):147-54. PubMed ID: 20560295
[TBL] [Abstract][Full Text] [Related]
29. Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis.
Ran B; Ren X; Lin X; Teng Y; Xin F; Ma W; Zhao X; Li M; Wang J; Wang C; Sun L; Zhang J
J Control Release; 2024 Jun; 370():811-820. PubMed ID: 38754632
[TBL] [Abstract][Full Text] [Related]
30. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
31. Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of Caveolin-1 and TGF-β1 Signal Pathway.
Zhan H; Huang F; Ma W; Zhao Z; Zhang H; Zhang C
Biol Pharm Bull; 2016; 39(8):1284-92. PubMed ID: 27476938
[TBL] [Abstract][Full Text] [Related]
32. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
Rashid J; Patel B; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
J Control Release; 2017 Mar; 250():96-106. PubMed ID: 28185800
[TBL] [Abstract][Full Text] [Related]
33. Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice.
Saito T; Kotani T; Suzuki K
Sci Rep; 2020 Nov; 10(1):19019. PubMed ID: 33149192
[TBL] [Abstract][Full Text] [Related]
34. Design and Characterizations of Inhalable Poly(lactic-
Sato H; Tabata A; Moritani T; Morinaga T; Mizumoto T; Seto Y; Onoue S
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183032
[TBL] [Abstract][Full Text] [Related]
35. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
36. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
[TBL] [Abstract][Full Text] [Related]
37. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
38. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
39. Antifibrosis effects of triterpene acids of Eriobotrya japonica (Thunb.) Lindl. leaf in a rat model of bleomycin-induced pulmonary fibrosis.
Yang Y; Huang Y; Huang C; Lv X; Liu L; Wang Y; Li J
J Pharm Pharmacol; 2012 Dec; 64(12):1751-60. PubMed ID: 23146038
[TBL] [Abstract][Full Text] [Related]
40. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
Selvam P; El-Sherbiny IM; Smyth HD
J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
